Table 4 The effects of Hsp expression on response to CRT
From: Prognostic role of HPV infection in esophageal squamous cell carcinoma
Molecular Marker | Clinical Downstaging (n = 74) | p value | ||
|---|---|---|---|---|
Responder | Non-Responder | |||
Hsp 16.2 | low intensity | 29 (82.9%) | 6 (17.1%) | p < 0.01 |
high intensity | 9 (23.1%) | 30 (76.9%) | ||
Hsp 27 | low intensity | 22 (61.1%) | 14 (38.9%) | p = 0.102 |
high intensity | 16 (42.1%) | 22 (57.9%) | ||
Hsp 90 | low intensity | 21 (84.0%) | 4 (16.0%) | p < 0.001 |
high intensity | 17 (34.7%) | 32 (65.3%) | ||